Gamma-globin gene promoter elements required for interaction with globin enhancers

Blood

Volumn 91, Issue 1, 1998, Pages 309-318

  Langdon, Scott D ^a   Kaufman, Russel E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; DNA; GAMMA GLOBIN; GLOBIN; HEMOGLOBIN F; LUCIFERASE; TRANSCRIPTION FACTOR GATA 1;

ANIMAL CELL; ARTICLE; BINDING SITE; ENHANCER REGION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 0031964974     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.1.309.309_309_318     Document Type: Article

References (76)

1. Stamatoyannopoulos G, Nienhuis AW: Hemoglobin switching, in Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus HE (eds): Molecular Basis of Blood Diseases. Philadelphia, PA, Saunders, 1993, p 107
2. Tuan D, Solomon W, Li Q, London IM: The "β-like-globin" gene domain in human erythroid cells. Proc Natl Acad Sci USA 82:6384, 1985
3. Forrester WC, Takegawa S, Papayannopoulou T, Stamatoyannopoulos G, Groudine M: Evidence for a locus activation region: The formation of developmentally stable hypersensitive sites in globin-expressing hybrids. Nucleic Acids Res 15:10159, 1987
4. Grosveld F, Blom van Assendelft G, Greaves DR, Kollias G: Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell 51:975, 1987
5. Orkin SH: Globin gene regulation and switching: Circa 1990. Cell 63:665, 1990
6. Forrester WC, Epner E, Driscol MC, Enver T, Brice M, Papayannopoulou T, Groudine M: A deletion of the human β-globin locus activation region causes a major alteration in chromatin structure and replication across the entire β-globin locus. Genes Dev 4:1637, 1990
7. Felsenfeld G: Chromatin as an essential part of the transcriptional mechanism. Nature 355:219, 1992
8. Ryan TM, Behringer RR, Martin NC, Townes TM, Palmiter RD, Brinster RL: A single erythroid-specific Dnase I super-hypersensitive site activates high levels of human β-globin gene expression in transgenic mice. Genes Dev 3:314, 1989
9. Curtin PT, Liu DP, Liu W, Chang JC, Kan YW: Human β-globin gene expression in transgenic mice is enhanced by a distant Dnase I hypersensitive site. Proc Natl Acad Sci USA 86:7082, 1989
10. Philipsen S, Talbot D, Fraser P, Grosveld F: The β-globin dominant region: Hypersensitive site 2. EMBO J 9:2159, 1990
11. Talbot D, Philipsen S, Fraser P, Grosveld F: Detailed analysis of the site 3 region of the human beta-globin dominant control region. EMBO J 9:2169, 1990
12. Pruzina S, Hanscombe O, Whyatt D, Grosveld F, Philipsen S: Hypersensitive site 4 of the human β-globin locus control region. Nucleic Acids Res 19:1413, 1991
13. Tuan DY, Solomon WB, London IM, Lee DP: An erythroid-specific, developmental-stage-independent enhancer far upstream of the human "beta-like globin" genes. Proc Natl Acad Sci USA 86:2554, 1989
14. Roberts NA, Sloane-Stanley JA, Sharpe JA, Wood WG: Globin gene switching in transgenic mice carrying HS2-globin gene construct. Blood 89:713, 1997
15. Sorrentino B, Ney P, Bodine D, Nienhuis AW: A 46 base pair enhancer sequence within the locus activating region is required for induced expression of the gamma-globin gene during erythroid differentiation. Nucleic Acids Res 18:2721, 1990
16. Ney PA, Sorrentino BP, Lowrey CH, Nienhuis AW: Inducibility of the HSII enhancer depends on binding of an erythroid specific nuclear-protein. Nucleic Acids Res 18:6011, 1990
17. Choi O-R, Engel JD: Developmental regulation of β-globin gene switching. Cell 55:17, 1988
18. Cavallesco R, Tuan, D: Modulatory subdomains of the HS2 enhancer differentially regulate enhancer activity in erythroid cells at different developmental stages. Blood Cells, Molecules, and Diseases 23:8, 1997
19. Ronchi A, Berry M, Raguz S, Imam A, Yannoutsos N, Ottolenghi, S, Grosveld F, Dillon N: Role of the duplicated CCAAT box region in γ globin gene regulation and hereditary persistence of fetal hemoglobin. EMBO J 15:143, 1996
20. Ikuta T, Kan YW: In vivo protein-DNA interactions at the β-globin gene locus. Proc Natl Acad Sci USA 88:10188, 1991
21. Martin DIK, Tsai S-F, Orkin SH: Increased γ-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor. Nature 338:435, 1989
22. Gumucio DL, Rood KL, Gray TA, Riordan MF, Sartor CI, Collins FS: Nuclear proteins that bind the human γ-globin gene promoter: Alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin. Mol Cell Biol 8:5310, 1988
23. Mantovani R, Malgaretti N, Nicolis S, Ronchi A, Giglioni B, Ottolenghi S: The effects of HPFH mutations in the human γ-globin promoter on binding of ubiquitous and erythroid specific nuclear factors. Nucleic Acids Res 16:7783, 1988
24. O'Neill D, Kaysen J, Donovan-Peluso M, Castle M, Bank A: Protein-DNA interactions upstream from the human A gamma globin gene. Nucleic Acids Res 18:1977, 1990
25. Mantovani R, Malgaretti N, Giglioni B, Comi P, Cappelini N, Nicolos S, Ottolenghi S: A protein factor binding to an octamer motif in the γ-globin promoter disappears upon induction of differentiation and hemoglobin synthesis is K562 cells. Nucleic Acids Res 15:9349, 1987
26. Jane SM, Ney PA, Vanin EF, Gumucio DL, Nienhuis AW: Identification of a human stage selector element in the human γ-globin gene promoter that fosters preferential interaction with the 5′HS2 enhancer when in competition with the β-promoter. EMBO J 11:2961, 1992
27. Anagnou NP, Karlsson S, Moulton AD, Keller G, Nienhuis AW: Promoter sequences required for function of the human gamma globin gene in erythroid cells. EMBO J 5:121, 1986
28. Aγ-globin gene. Nucleic Acids Res 17:3811, 1989
29. Gumucio DL, Rood KL, Blanchard-McQuate KL, Gray TA, Saulino A, Collins FS: Interaction of Sp1 with the human γ globin promoter: Binding and transactivation of normal and mutant promoters. Blood 78:1853, 1991
30. McDonagh KT, Lin HJ, Lowrey CH, Bodine DM, Nienhuis AW: The upstream region of the human γ-globin gene promoter. J Biol Chem 266:11965, 1991
31. Ulrich MJ, Ley TJ: Function of normal and mutated γ-globin gene promoters in electroporated K562 erythroleukemia cells. Blood 75:990, 1990
32. Lin HJ, Anagnou NP, Rutherford TR, Shimada T, Nienhuis AW: Activation of the human β-globin promoter in K562 cells by DNA sequences 5′ to the fetal γ-or embryonic ζ-globin genes. J Clin Invest 80:374, 1987
33. Gγ-globin promoter elements and the adult β-globin 3′ enhancer in the stage-specific expression of globin genes. Mol Cell Biol 10:1116, 1990
34. 34: Antoniou M, Grosveld F: β-Globin dominant control region interacts differently with distal and proximal promoter elements. Genes Dev 4:1007, 1990
35. Donze D, Townes TM, Bieker JJ: Role of erythroid Kruppel-like factor in human γ-to β-globin gene switching. J Biol Chem 270:1955, 1995
36. Gong Q-H, Stern J, Dean A: Transcriptional role of a conserved GATA-1 site in the human ε-giobin gene promoter. Mol Cell Biol 11:2558, 1991
37. Brasier AR, Tate JE, Habener JF: Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 7:1116, 1989
38. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Strahl K: Current Protocols in Molecular Biology. New York, NY, Wiley-Interscience, 1991 p 857 (suppl 15)
39. Berger J, Hauber J, Hauber R, Geiger R, Cullen BR: Secreted placental alkaline phosphatase: A powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66:4, 1988
40. De Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S: Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol 7:725, 1987
41. Miller JH: Experiments in Molecular Genetics. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1972
42. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248, 1976
43. Moon AM, Ley TJ: Functional properties of the β-globin locus control region in K562 erythroleukemia cells. Blood 77:2272, 1991
44. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475, 1983
45. Sykes K, Kaufman RE: A naturally occuring gamma globin gene mutation enhances SP1 binding activity. Mol Cell Biol 10:95, 1990
46. Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JN: Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185:60, 1990
47. Rutherford TR, Clegg JB, Weatherall DJ: K562 human leukaemic cells synthesize embryonic haemoglobin in response to haemin. Nature 280:164, 1979
48. Charnay P, Treisman R, Mellon P, Chao M, Axel R, Maniatic T: Differences in human α- and β-globin gene expression in mouse erythroleukemia cells: The role of intragenic sequences. Cell 38:251, 1984
49. Fischer K-D, Haese A, Nowock J: Cooperation of GATA-1 and Sp1 can result in synergistic transcriptional activation or interference. J Biol Chem 268:23915, 1993
50. Tagle DA, Koop BF, Goodman M, Slightom JL, Hess DL, Jones RT: Embryonic ε and γ globin genes of a prosimian primate (Galago crassicaudatus). J Mol Biol 203:439, 1988
51. Gumucio DL, Lockwood WK, Weber JL, Saulino AM, Delgrosso K, Surrey S, Schwartz E, Goodman M, Collins FS: The -175 T→C mutation increases promoter strength in erythroid cells: Correlation with evolutionary conservation of binding sites for two trans-acting factors. Blood 75:756, 1990
52. Lloyd JA, Lee RF, Lingrel JB: Mutations in two regions of the A gamma globin gene canonical promoter affect gene expression. Nucleic Acids Res 17:4339, 1989
53. Nicolis S, Ronchi A, Malgaretti N, Mantovani R, Giglioni B, Ottolenghi S: Increased erythroid-specific expression of a mutated HPFH gamma-globin promoter requires the erythroid factor NFE-1. Nucleic Acids Res 17:5509, 1989
54. Ney PA, Sorrentino BP, McDonagh KT, Nienhuis AW: Tandem AP-1-binding sites within the human β-globin dominant control region function as an inducible enhancer in erythroid cells. Genes Dev 4:993, 1990
55. Moi P, Kan YW: Synergistic enhancement of globin gene expression by activator protein-1-like proteins. Proc Natl Acad Sci USA 87:9000, 1990
56. Motamed K, Bastiani C, Zhang Q, Bailey A, Shen CK: CACC box and enhancer response of the human embryonic epsilon globin promoter. Gene 123:235, 1993
57. Superti-Furga G, Barberia A, Schaffner G, Busslinger M: The -117 mutation in Greek HPFH affects the binding of three nuclear factors to the CCAAT region of the γ-globin gene. EMBO J 7:3099, 1988
58. Delvoye NL, Destroismaisons NM, Wall LA: Activation of the β-globin promoter by the locus control region correlates wim binding of a novel factor to the CAAT box in murine erythroleukemia cells but not in K562 cells. Mol Cell Biol 3:6969, 1993
59. Berry M, Grosveld F, Dillon N: A single point mutation is the cause of the Greek form of hereditary persistence of fetal hemoglobin. Nature 358:499, 1992
60. Gγ-globin gene in the Japanese HPFH: Implication of factor binding in elevated fetal globin expression. Nucleic Acids Res 18:5245, 1990
61. Katsube T, Fukumaki Y: A Role for the Distant CCAAT Box of the γ-globin gene in Hb switching. J Biochem 117:68, 1995
62. Ronchi AE, Bottardi S, Mazzucchelli C, Ottolenghi S, Santoro C: Differential binding of the NFE3 and CP1/NFY transcription factors in the human γ- and ε-globin CCAAT boxes. J Biol Chem 270:21934, 1995
63. Bieker JJ, Southwood CM: The erythroid Kruppel-like factor transactivation domain is a critical component for cell-specific inducibility of a β-globin promoter. Mol Cell Biol 15:852, 1995
64. Stamatoyannopoulos G, Josephson B, Zhang J-W, Li Q: Developmental regulation of human γ-globin genes in transgenic mice. Mol Cell Biol 13:7636, 1993
65. Matsuda M, Sakamoto N, Fukumaki Y: δ-thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the δ-globin gene promoter. Blood 80:1347, 1992
66. Raich N, Clegg CH, Grofti J, Romeo P-H, Stamatoyannopoulos G: GATA1 and YY1 are developmental repressors of the human ε-globin gene. EMBO J 14:801, 1995
67. Aγ-globin gene promoter. Blood 82:1344, 1993
68. Tuan D, Feingold E, Newman M, Weissman SM, Forget BG: Different 3′ endpoints of deletion causing δβ-thalassemia and hereditary persistence of fetal hemoglobin: Implications for the control of γ gene expression in man. Proc Natl Acad Sci USA 80:6937, 1983
69. Feingold EA, Collins FS, Metherall JE, Stoeckert CJ Jr, Weissman SM, Forget BG: Analysis of mutations associated with deletion and non-deletion hereditary persistence of fetal hemoglobin, in Stamatoyannopoulos G, Nienhuis AW (eds): Experimental Approaches for the Study of Hemoglobin Switching. New York, NY, Liss, 1985, p 107
70. Jane SM, Gumucio DL, Ney PA, Cunningham JM, Nienhuis AW: Methylation-enhanced binding of Sp1 to the stage selector element of the human γ-globin gene promoter may regulate developmental specificity of expression. Mol Cell Biol 13:3272, 1993
71. Ronchi A, Nicolis S, Santoro C, Ottolenghi S: Increased Sp1 binding mediates erythroid-specific overexpression of a mutated (HPFH) γ-globin promoter. Nucleuc Acids Res 17:10231, 1989
72. Reddy PMS, Stamatoyannopoulos G, Papayannopoulou T, Shen C-K J: Genomic footprinring and sequencing of human β-globin locus. J Biol Chem 269:8287, 1994
73. Bresnick EH, Felsenfeld G: Evidence that the transcription factor USF is a component of the human β-globin locus control region heteromeric protein complex. J Biol Chem 268:18824, 1993
74. Ellis J, Talbot D, Dillon N, Grosveld F: Synthetic human β globin 5′HS2 constructs function as locus control regions only in multicopy transgene concatamers. EMBO J 12:127, 1993
75. Caterina JJ, Ciavatta DJ, Donze D, Behringer RR, Townes TM: Multiple elements in human β-globin locus control region 5′HS2 are involved in enhancer activity and position-independent transgene expression. Nucleic Acids Res 22:1006, 1994
76. Talbot D, Grosveld F: The 5′HS2 of the globin locus control region enhances transcription through the interaction of a multimeric complex binding at two functionally distinct NF-E2 binding sites. EMBO J 10:1391, 1991